Effects of cabergoline in a pituitary adenoma secreting follicle-stimulating hormone

Postgraduate Medical Journal

Volumn 73, Issue 862, 1997, Pages 507-508

  Leese, Graham ^a,c   Jeffreys, Richard ^b   Vora, Jiten ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b WALTON HOSPITAL   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cabergoline; Follicle stimulating hormone; Pituitary adenoma

Indexed keywords

CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; FOLLITROPIN;

ABSCESS; ABSCESS DRAINAGE; ADULT; ARTICLE; CASE REPORT; FOLLITROPIN RELEASE; HUMAN; HYPOPHYSIS ADENOMA; MALE; PRIMARY HYPERALDOSTERONISM; STAPHYLOCOCCUS AUREUS; SYMPTOM; TRANSSPHENOIDAL SURGERY;

EID: 0030804434     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.73.862.507     Document Type: Article

References (10)

1. Bevan JS, Burke CW. Non-functioning pituitary adenomas do not regress during bromocriptine therapy but possess membrane bound dopamine receptors which bind bromocriptine. Clin Endocrinol 1986; 25: 561-72.
2. Van Schaardenburg D, Roelfsema F, Van Seters AP, Vielvoye GJ. Bromocriptine therapy for non-functioning pituitary adenoma. Clin Endocrinol 1989; 30: 475-84.
3. Liuzzi A, Chiodini PG, Dallabonzana D, Oppizzi G, Verde GG. Medical treatment of pituitary adenomas: effects on tumour growth. (Review article) J Endocrinol Invest 1985; 8: 273-81.
4. Barrow DL, Tindall GT, Kovacs K, Thorner MO, Horvath E, Huffman JC. Clinical and pathological effects of bromocriptine on prolactin secreting and other pituitarytumors. J Neurosurg 1984; 60: 1-7.
5. Grossman A, Ross R, Charlesworth M, et al. The effect of dopamine agonist therapy on large functionless pituitary tumours. Clin Endocrinol 1985; 22: 679-86.
6. Berezin M, Olchovsky D, Pines A, Tadmor R, Lunefeld B. Reduction of follicle stimulating hormone secretion in FSH-producing pituitary adenoma by bromocriptine. J Clin Endocrinol Metab 1984; 59: 1220-3.
7. Vance ML, Ridgway EC, Thomer MO. Follicle stimulating hormone and alpha subunit secreting pituitary tumor treated with bromocriptine. J Clin Endocrinol Aletab 1985; 61: 580-4.
8. Abs R, Parizel PM, Beckers A. Acute effects of parlodelLAR and responses to long-term treatment with bromocriptine in a patient with a follicle stimulating hormonesecreting pituitary adenoma. J Endocrinol Imcsi 1991; 14: 135-8.
9. Paoletti AM, Depau GF, Mais V, Guerriere S, Ajossa S, Melis GB. Effectiveness of cabergoline in reducing folliclestimulating hormone and prolactin hypersecretion from pituitary macroadenoma in an infertile woman. Fertil Steril 1994; 62: 882-5.
10. Kwekkeboom DJ, Lamberts S\V. Long-term treatment with the dopamine agonist CV 205-502 of patients with clinically non-functioning, gonadotroph, or a-subunit secreting pituitary adenoma. Clin Endocrinol 1992; 36: 171-6.